Results 281 to 281 of about 212,208 (281)

TALON Phase IIIb Study: 32-Week Primary Results of Brolucizumab Using Treat and Extend for Neovascular Age-Related Macular Degeneration

Ophthalmology Retina
Peter K Kaiser, Frank G Holz, Peter Kertes   +2 more
exaly